Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Neil

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 1, 1988
Organizing for drug discoveryM Williams, G L Neil
Cancer Chemotherapy Reports|May 1, 1975
Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in miceR H Liss, G L Neil
Cancer Research|June 1, 1977
Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosineD H Ho, G L Neil
Advances in Enzyme Regulation|January 1, 1985
Acivicin in 1985R H Earhart, G L Neil
Cancer Research|April 1, 1973
The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitorsG L Neil, E R Homan
Lloydia|March 1, 1978
In vitro methods used in detection and quantitation of antitumor drugs produced by microbial fermentationsL J Hanka, D G Martin, G L Neil
Cancer Research|August 1, 1970
Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic miceG L Neil, T E Moxley, R C Manak
Cancer Chemotherapy Reports|December 1, 1970
Improved microbiological assay for cytosine arabinoside (NSC-63878)L J Hanka, S L Kuentzel, G L Neil
Journal of Medicinal Chemistry|September 1, 1971
Nucleic acids. 12. Synthesis of the L enantiomer of 1- -arabinofuranosylcytosine and of O 2 ,O 2' -anhydro-1- -D-arabinofuranosylcytosineD T Gish, G L Neil, W J Wechter
Cancer Chemotherapy Reports|November 1, 1974
A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivoD G Martin, L J Hanka, G L Neil
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 1, 1988
Organizing for drug discoveryM Williams, G L Neil
Cancer Chemotherapy Reports|May 1, 1975
Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in miceR H Liss, G L Neil
Cancer Research|June 1, 1977
Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosineD H Ho, G L Neil
Advances in Enzyme Regulation|January 1, 1985
Acivicin in 1985R H Earhart, G L Neil
Cancer Research|April 1, 1973
The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitorsG L Neil, E R Homan
Lloydia|March 1, 1978
In vitro methods used in detection and quantitation of antitumor drugs produced by microbial fermentationsL J Hanka, D G Martin, G L Neil
Cancer Research|August 1, 1970
Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic miceG L Neil, T E Moxley, R C Manak
Cancer Chemotherapy Reports|December 1, 1970
Improved microbiological assay for cytosine arabinoside (NSC-63878)L J Hanka, S L Kuentzel, G L Neil
Journal of Medicinal Chemistry|September 1, 1971
Nucleic acids. 12. Synthesis of the L enantiomer of 1- -arabinofuranosylcytosine and of O 2 ,O 2' -anhydro-1- -D-arabinofuranosylcytosineD T Gish, G L Neil, W J Wechter
Cancer Chemotherapy Reports|November 1, 1974
A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivoD G Martin, L J Hanka, G L Neil
Pageof 5